Every Prostate Cancer Journey Is Different: How Imaging Can Help

September is Prostate Cancer Awareness Month, a time to encourage awareness, early detection, and informed conversations about prostate health.

A prostate cancer diagnosis can bring many questions. What stage is the cancer? Has it spread? What treatment is right for me? And what happens next?

The answers can be different for every patient.

Today, advances in medical imaging are helping physicians get a more personalized view of prostate cancer—providing information that can help guide decisions throughout a patient’s cancer journey.

Your Diagnosis Is Personal. Your Imaging Should Be, Too.

No two prostate cancers are exactly alike. Some cancers remain confined to the prostate, while others may spread to nearby lymph nodes, bones, or other parts of the body.

Understanding where prostate cancer is located can be an important part of determining the next step in care.

That’s one reason advanced imaging, including PSMA PET/CT, has become an important tool in prostate cancer management.

Going Beyond “Is Cancer Present?”

Traditional tests can provide important information about prostate cancer, but physicians may need a more detailed picture to understand the extent of disease.

PSMA PET/CT uses a specialized tracer that targets prostate-specific membrane antigen (PSMA), a protein found in high amounts on most prostate cancer cells.

The PET scan detects areas where the tracer collects, while the CT provides detailed anatomical information. Together, they can help physicians identify prostate cancer throughout the body.

This can provide valuable information about whether cancer is confined to the prostate or has spread to areas such as the lymph nodes, bones, or soft tissues.

When Can Personalized Imaging Be Helpful?

PSMA PET/CT may be used for men in several different situations.

Newly Diagnosed Prostate Cancer

For men with certain higher-risk prostate cancers, PSMA PET/CT may help determine whether cancer has spread before treatment begins.

Having a clearer understanding of the disease can help the care team develop a treatment strategy based on the individual patient.

Suspected Recurrence

A rising PSA after treatment can be concerning for recurrent prostate cancer.

PSMA PET/CT may help locate areas of recurrent disease, providing information that can be difficult to obtain through conventional imaging alone.

Advanced or Metastatic Prostate Cancer

When prostate cancer has spread, knowing where the disease is located can help physicians monitor its progression and make decisions about ongoing treatment.

From Seeing Cancer to Targeting It

One of the most exciting developments in prostate cancer care is the connection between diagnostic imaging and targeted treatment.

This approach is known as theranostics—a combination of therapy and diagnostics.

In simple terms, the process can be thought of as:

Find it. Confirm it. Target it. Treat it.

PSMA PET imaging can identify prostate cancer cells that express PSMA. For appropriate patients, this information may help determine whether they could benefit from a PSMA-targeted therapy.

TRA Medical Imaging offers theranostic treatment options for eligible patients with PSMA-positive prostate cancer, including Lutetium-177 PSMA (Pluvicto).

This personalized approach represents an important advancement in how certain advanced prostate cancers can be managed.

Questions to Ask Your Care Team

If you or a loved one has been diagnosed with prostate cancer, consider asking your healthcare provider:

• What stage is my prostate cancer?
• Has my cancer spread beyond the prostate?
• Would PSMA PET/CT provide additional information about my disease?
• How could advanced imaging affect my treatment plan?
• Am I a candidate for PSMA-targeted therapy or theranostics?

Your healthcare provider can help determine which tests and treatments are appropriate based on your individual diagnosis, medical history, and treatment goals.

Advanced Prostate Cancer Imaging Close to Home

At TRA Medical Imaging, we’re proud to offer PSMA PET/CT in the South Puget Sound, giving patients access to advanced prostate cancer imaging close to home.

Our PET/CT team works with referring providers to provide detailed imaging that can help inform the next steps in a patient’s care. For eligible patients, TRA also offers theranostic treatment options for PSMA-positive prostate cancer.

If you have questions about PSMA PET/CT, speak with your healthcare provider or contact the TRA PET/CT Specialty Coordinators at 253-680-3400.

This Prostate Cancer Awareness Month, Make Your Care Personal

Prostate cancer is not one-size-fits-all—and neither should the conversation surrounding your care be.

Advances in imaging are giving physicians more information than ever before, helping them better understand each patient’s disease and make more informed treatment decisions.

If you or someone you love is navigating prostate cancer, ask questions, understand your options, and talk with your care team about whether advanced imaging may be appropriate.

Your diagnosis is personal. Your care should be, too.

TRA Medical Imaging — Advanced imaging and theranostic care, closer to home.